Last Updated:
Searching
Create account to add to watchlist!

Oxus Acquisition Corp. - OXUS

  • Commons

    $9.95

    +0.00%

    OXUS Vol: 3.5K

  • Warrants

    $0.70

    -5.41%

    OXUSW Vol: 39.6K

  • Units

    $10.61

    -0.28%

    OXUSU Vol: 0.0

Average: 5
Rating Count: 1
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 174.6M
Average Volume: 108.9K
52W Range: $9.76 - $10.14
Weekly %: +0.00%
Monthly %: +0.45%
Inst Owners: 1

Info

Target: Searching
Days Since IPO: 86
Unit composition:
Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one warrant
Trust Size: 15000000.0M

🕵Stocktwit Mentions

beenwilli posted at 2021-11-26T15:29:35Z

$OXUS is anyone buying commons too? The Storedot DD looks very good

wreed11 posted at 2021-11-25T19:23:29Z

$OXUS happy Turkey Day y’all, Big question for me is not if StoreDot but when, before 2022? News drops seem to be readying for something. Let’s do this. Im in warrants heavy.

happyflyingbuttmonkey posted at 2021-11-25T15:05:30Z

$OXUS It's down to either this company or burgundy in my

happyflyingbuttmonkey posted at 2021-11-25T13:52:41Z

$OXUS I think JP Morgan recently drowngraded Quantumscape due to "new competition" or something like

happyflyingbuttmonkey posted at 2021-11-25T13:49:58Z

$OXUS I want to thank you all the DD.... I've been waiting for this company for 11 months.... ever since reading about them late last

Markymar posted at 2021-11-25T02:30:59Z

$OXUS I got more DD also I’ll be posting later Maybe tomorrow

Markymar posted at 2021-11-25T02:30:31Z

$OXUS

happyflyingbuttmonkey posted at 2021-11-24T23:30:29Z

$OXUS I'm in at 9.97 and buying the dips to average down

FraGmE posted at 2021-11-24T20:24:44Z

$OXUS the warrants are holding up well so far in this blood bath week.

J_Will posted at 2021-11-24T20:02:19Z

$OXUS Warrants!!! Num nun num

barada posted at 2021-11-24T20:00:03Z

$OXUS Accumulating warrants under a buck.

usamccarty posted at 2021-11-24T19:53:51Z

$OXUS @TheMaster I know you like battery plays and nano one tech. (Me too) I’d love your opinion if this becomes StoreDot. Check out the DD some of these Oxus friends found. 5 minute charging and partners with Daimler/BP.

BB36 posted at 2021-11-24T14:21:45Z

$OXUS next week I think news. I also not very smart so likely I wrong.

Chickenswelldone posted at 2021-11-24T00:21:51Z

$OXUS StoreDot.

bird1976 posted at 2021-11-23T23:08:27Z

$OXUS interesting read and more insight https://www.seoraksantimes.com/does-kenes-rakishev-plan-to-disrupt-battery-technology-with-the-oxus-target/

Georgea8 posted at 2021-11-23T20:55:49Z

$OXUS if this is storedot, what sort of price are we looking at on da?

BB36 posted at 2021-11-23T17:53:41Z

$OXUS alright next week we get info? Looks possible.

GeeMoney26 posted at 2021-11-23T16:04:48Z

$OXUS https://www.kenesrakishev.com/investments/storedot/

GeeMoney26 posted at 2021-11-23T15:59:04Z

$OXUS https://www.calcalistech.com/ctech/articles/0,7340,L-3899283,00.html

starteasy posted at 2021-11-23T07:33:37Z

$OXUS According to Forbes Rakishev's net worth is 890 million. Storedot is also mentioned on his personal website: kengesrakishev.com ....lookin good !!!

thestocksdealer posted at 2021-11-22T22:05:46Z

$OXUS $KSI $BTAQ market over reaction to j Powell renomination? 😂 buy the dip for December rally

SpacThatAsk posted at 2021-11-22T18:41:00Z

$OXUS move that .80 wall up on warrants lol

Rocketbuller posted at 2021-11-22T18:29:52Z

$OXUS In for 7k warrants today, worth the gamble.

Nobody000 posted at 2021-11-22T18:06:31Z

$OXUS

The_Snowman_10_4 posted at 2021-11-22T17:50:02Z

$OXUS ok, you all convinced me. I bought 4400 warrants this morning.

bird1976 posted at 2021-11-22T16:30:48Z

$OXUS 80s on the warrants will be owned today :) and than its dollar land. I think we see volume roll in, in the afternoon

Georgea8 posted at 2021-11-22T15:56:32Z

$OXUS these guys only have $175m? do you think thats enough for storedot

spachodl posted at 2021-11-22T15:32:39Z

$OXUS Where do you see warrants end up if its indeed Storedot?

bird1976 posted at 2021-11-22T14:55:29Z

$OXUS here we go again. I know someone waiting to load up on those warrants if it hands here. I told him its not gonna stick here, so watch for a big buy. If we get any mention of OXUS and Storedot in another article drop, see you later it will rocket

usamccarty posted at 2021-11-22T14:41:34Z

$OXUS I'm in - @TheMaster - Feels like a cciv party in here before lucid was announced. I appreciate the DD from everyone

Management

Officers and Directors We intend to have five directors upon completion of this offering. Our board of directors will be divided into three classes with only one class of directors being elected in each year and each class (except for those directors appointed prior to our first annual meeting of shareholders) serving a three-year term. The term of office of the first class of directors, consisting of Sergey Ivashkovsky, will expire at our first annual meeting of shareholders. The term of office of the second class of directors, consisting of Christophe Charlier and Shiv Vikram Khemka, will expire at our second annual meeting of shareholders. The term of office of the third class of directors, consisting of Kenges Rakishev and Kanat Mynzhanov, will expire at our third annual meeting of shareholders. We may not hold an annual meeting of shareholders until after we consummate our initial business combination. Prior to the completion of our initial business combination, any vacancy on our board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint officers as it deems appropriate pursuant to our amended and restated memorandum and articles of association. Executive Compensation No executive officer has received any cash compensation for services rendered to us. Commencing on the date of this prospectus through the acquisition of a target business or our liquidation of the trust account, we will pay our sponsor $10,000 per month for providing us with general and administrative services, including office space, utilities and administrative support. However, this arrangement is solely for our benefit and is not intended to provide our officers or directors compensation in lieu of a salary. Other than the $10,000 per month administrative fee and the repayment of up to $300,000 in loans from our sponsor, no compensation or fees of any kind, including finder’s, consulting fees and other similar fees, will be paid to our sponsor, initial shareholders, members of our management team or their respective affiliates, for services rendered prior to or in connection with the consummation of our initial business combination (regardless of the type of transaction that it is). However, they will receive reimbursement for any out-of-pocket expenses incurred by them in connection with activities on our behalf, such as identifying potential target businesses, performing business due diligence on suitable target businesses and business combinations as well as traveling to and from the offices, plants or similar locations of prospective target businesses to examine their operations. There is no limit on the amount of out-of-pocket expenses reimbursable by us. After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials furnished to our shareholders. However, the amount of such compensation may not be known at the time of the shareholder meeting held to consider an initial business combination, as it will be up to the directors of the post-combination business to determine executive and director compensation. In this event, such compensation will be publicly disclosed at the time of its determination in a Current Report on Form 8-K or a periodic report, as required by the SEC. 82 Table of Contents Director Independence Currently, Christophe Charlier, Sergei Ivaskhovksy and Shiv Vikram Khemka would each be considered an “independent director” under the Nasdaq listing rules, which is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship, which, in the opinion of the company’s board of directors would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Any affiliated transactions will be on terms no less favorable to us than could be obtained from independent parties. Our board of directors will review and approve all affiliated transactions with any interested director abstaining from such review and approval. Audit Committee Effective upon the date of this prospectus, we will establish an audit committee of the board of directors, which will consist of Christophe Charlier (chairman), Shiv Vikram Khemka and Sergei Ivashkovsky, each of whom is an independent director under Nasdaq’s listing standards. The audit committee’s duties, which are specified in our Audit Committee Charter, include, but are not limited to: • reviewing and discussing with management and the independent auditor the annual audited financial statements, and recommending to the board whether the audited financial statements should be included in our Form 10-K; • discussing with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation of our financial statements; • discussing with management major risk assessment and risk management policies; • monitoring the independence of the independent auditor; • verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; • reviewing and approving all related party transactions; • inquiring and discussing with management our compliance with applicable laws and regulations; • pre-approving all audit services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of the services to be performed; • appointing or replacing the independent auditor; • determining the compensation and oversight of the work of the independent auditor (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; • establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; and • approving reimbursement of expenses incurred by our management team in identifying potential target businesses. 83 Table of Contents Financial Experts on Audit Committee The audit committee will at all times be composed exclusively of “independent directors” who are “financially literate” as defined under Nasdaq’s listing standards. Nasdaq’s standards define “financially literate” as being able to read and understand fundamental financial statements, including a company’s balance sheet, income statement and cash flow statement. In addition, we must certify to Nasdaq that the committee has, and will continue to have, at least one member who has past employment experience in finance or accounting, requisite professional certification in accounting, or other comparable experience or background that results in the individual’s financial sophistication. The board of directors has determined that Christophe Charlier qualifies as an “audit committee financial expert,” as defined under rules and regulations of the SEC. Nominating Committee Effective upon the date of this prospectus, we will establish a nominating committee of the board of directors, which will consist of Christophe Charlier (chairman), Shiv Vikram Khemka and Sergei Ivashkovsky, each of whom is an independent director under Nasdaq’s listing standards. The nominating committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The nominating committee considers persons identified by its members, management, shareholders, investment bankers and others. Guidelines for Selecting Director Nominees The guidelines for selecting nominees, which are specified in the Nominating Committee Charter, generally provide that persons to be nominated: • should have demonstrated notable or significant achievements in business, education or public service; • should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and • should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders. The Nominating Committee will consider a number of qualifications relating to management and leadership experience, background and integrity and professionalism in evaluating a person’s candidacy for membership on the board of directors. The nominating committee may require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating committee does not distinguish among nominees recommended by shareholders and other persons. Compensation Committee Effective upon the date of this prospectus, we will establish a compensation committee of the board of directors, which will consist of Christophe Charlier (chairman), Shiv Vikram Khemka and Sergei Ivashkovsky, each of whom is an independent director under Nasdaq’s listing standards. The compensation committee’s duties, which are specified in our Compensation Committee Charter, include, but are not limited to: • reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; • reviewing and approving the compensation of all of our other executive officers; • reviewing our executive compensation policies and plans; 84 Table of Contents • implementing and administering our incentive compensation equity-based remuneration plans; • assisting management in complying with our proxy statement and annual report disclosure requirements; • approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; • if required, producing a report on executive compensation to be included in our annual proxy statement; and • reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. Code of Ethics Effective upon consummation of this offering, we will adopt a code of ethics that applies to all of our executive officers, directors and employees. The code of ethics codifies the business and ethical principles that govern all aspects of our business. Conflicts of Interest Under Cayman Islands law, directors and officers owe the following fiduciary duties: (i) duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; (ii) duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; (iii) directors should not improperly fetter the exercise of future discretion; (iv) duty to exercise powers fairly as between different sections of shareholders; (v) duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and (vi) duty to exercise independent judgment. In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience of that director. As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the memorandum and articles of association or alternatively by shareholder approval at general meetings. Each of our officers and directors presently has, and any of them in the future may have additional, fiduciary or contractual obligations to at least one other entity pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. Our amended and restated memorandum and articles of association will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and it is an opportunity that we are able to complete on a reasonable basis. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination. 85 Table of Contents The following table summarizes the relevant pre-existing fiduciary or contractual obligations of our officers and directors besides our sponsor: Name of Individual Name of Affiliated Entity Kenges Rakishev Fincraft Group LLP, Fincraft Investments LLP, Fincraft Investment House JSC, Fincraft Resources JSC, Nebo Aviation PTE.LTD, Oxus Capital Pte. Ltd, Net Element, Inc., Multipoint Investments LLC, Fincraft Holdings Ltd, Sirin SARL, SDB Group LLP, Hikmet Travel LLP, Evoshave Limited, BTA Bank JSC, Battery Metals Technologies Ltd., Kazakhstan Boxing Federation, Satbayev Kazakh National Technical University, Young Entrepreneurs Association (Kazakhstan), YPO (Kazakhstan), Kanat Mynzhanov Bellprescot Prime Fund Askar Mametov Kaznedraproject LLP Sergey Ivashkovsky Eurasia Investment Partners, Fincraft Resources JSC Christophe Charlier La Française de l’Energie and Pure Grass Films Shiv Vikram Khemka SRL 142 Holdings Ltd., SUN Natural Resources Limited, SUN Assets Management Ltd., SUN Technology Investors Ltd. , SUN Group Holdings Ltd. Investors should also be aware of the following additional potential conflicts of interest: • None of our officers and directors is required to commit their full time to our affairs and, accordingly, they may have conflicts of interest in allocating their time among various business activities. • Unless we consummate our initial business combination, our officers, directors and sponsor will not receive reimbursement or repayment for any out-of-pocket expenses incurred by them, or loans made to us, to the extent that such expenses exceed the amount of available proceeds not deposited in the trust account or interest earned on the trust account funds that are available to us. • The founder shares beneficially owned by our initial shareholders will be released from escrow only if a business combination is successfully completed, and the private warrants purchased by our sponsor, and any warrants which our officers or directors may purchase in the aftermarket will expire worthless if a business combination is not consummated. Additionally, our officers and directors and affiliates will not receive liquidation distributions from the trust account with respect to any of the founder shares or private shares. Furthermore, our initial shareholders have agreed that the private warrants will not be sold or transferred by them until after we have completed a business combination. For the foregoing reasons, our board may have a conflict of interest in determining whether a particular target business is appropriate to effect a business combination with. To further minimize conflicts of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our officers, directors, sponsor or initial shareholders unless we have obtained an opinion from an independent investment banking firm, or another independent entity that commonly renders valuation opinions, that the business combination is fair to our unaffiliated shareholders from a financial point of view. We will also need to obtain the approval of a majority of our disinterested independent directors. Furthermore, in no event will any of our sponsor, initial shareholders, members of our management team or their respective affiliates be paid any compensation prior to, or for any services they render in order to effectuate, the consummation of an initial business combination (regardless of the type of transaction that it is) other than the $10,000 per month administrative fee, repayment of up to $300,000 in loans from our sponsor and reimbursement of any out-of-pocket expenses. 86 Table of Contents PRINCIPAL SHAREHOLDERS The following table sets forth information regarding the beneficial ownership of our ordinary shares as of the date of this prospectus and as adjusted to reflect the sale of our ordinary shares included in the units offered by this prospectus and included in the private warrants (assuming none of the individuals listed purchase units in this offering), by: • each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares; • each of our officers and directors; and • all of our officers and directors as a group. Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them. The following table does not reflect record of beneficial ownership of the warrants included in the units offered by this prospectus or the private warrants as these warrants are not exercisable within 60 days of the date of this prospectus. The post-offering numbers and percentages presented in the following table assume that the underwriters do not exercise their over-allotment option, that our initial shareholders forfeit 562,500 founder shares and that there are 19,050,000 ordinary shares issued and outstanding after this offering. Prior to Offering After Offering Name and Address of Beneficial Owner(1) Amount and Nature of Beneficial Ownership(2) Approximate Percentage of Outstanding Ordinary Shares Amount and Nature of Beneficial Ownership(2) Approximate Percentage of Outstanding Ordinary Shares Oxus Capital PTE. LTD.(3) 7,037,500 93.9 % 6,100,000 19.3 % Kenges Rakishev(3) 7,037,500 93.9 % 6,100,000 19.3 %

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 6.82%
% of Float Held by Institutions 6.82%
Number of Institutions Holding Shares 1

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q QUARTERLY REPORT 2021-11-15 https://www.sec.gov/Archives/edgar/data/1852973/000121390021059540/f10q0921_oxusacq.htm
SC 13G 2021-09-20 https://www.sec.gov/Archives/edgar/data/1852973/000090266421004272/p21-2176sc13g.htm
8-K CURRENT REPORT 2021-09-15 https://www.sec.gov/Archives/edgar/data/1852973/000121390021048045/ea147186-8k_oxusacq.htm
8-K CURRENT REPORT 2021-09-09 https://www.sec.gov/Archives/edgar/data/1852973/000121390021047172/ea147100-8k_oxusacq.htm
424B4 PROSPECTUS 2021-09-07 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046815/f424b40921_oxusacq.htm
EFFECT 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/999999999521003393/xslEFFECTX01/primary_doc.xml
3 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046487/xslF345X02/ownership.xml
3 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046486/xslF345X02/ownership.xml
3 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046484/xslF345X02/ownership.xml
3 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046483/xslF345X02/ownership.xml
3 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046482/xslF345X02/ownership.xml
3 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046481/xslF345X02/ownership.xml
3 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046480/xslF345X02/ownership.xml
CERT 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000135445721001005/8-ACert_OXUS.pdf
8-A12B 8-A12B 2021-09-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021046280/ea146821-8a12b_oxusacq.htm
CORRESP 2021-08-31 https://www.sec.gov/Archives/edgar/data/1852973/000121390021045886/filename1.htm
CORRESP 2021-08-31 https://www.sec.gov/Archives/edgar/data/1852973/000121390021045882/filename1.htm
CORRESP 2021-08-19 https://www.sec.gov/Archives/edgar/data/1852973/000121390021043851/filename1.htm
S-1/A REGISTRATION STATEMENT 2021-08-19 https://www.sec.gov/Archives/edgar/data/1852973/000121390021043849/fs12021a1_oxusacq.htm
UPLOAD 2021-08-12 https://www.sec.gov/Archives/edgar/data/1852973/000000000021009882/filename1.pdf
S-1 REGISTRATION STATEMENT 2021-07-27 https://www.sec.gov/Archives/edgar/data/1852973/000121390021038735/fs12021_oxusacq.htm
CORRESP 2021-07-26 https://www.sec.gov/Archives/edgar/data/1852973/000121390021038736/filename1.htm
UPLOAD 2021-04-29 https://www.sec.gov/Archives/edgar/data/1852973/000000000021005479/filename1.pdf
DRS 2021-04-02 https://www.sec.gov/Archives/edgar/data/1852973/000121390021019785/filename1.htm